These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18629645)

  • 1. RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis.
    Molnar T; Farkas K; Szepes Z; Nagy F; Nyari T; Wittmann T
    Dig Dis Sci; 2008 Oct; 53(10):2828-9. PubMed ID: 18629645
    [No Abstract]   [Full Text] [Related]  

  • 2. RDW as an additional marker in inflammatory bowel disease/undifferentiated colitis.
    Clarke K; Sagunarthy R; Kansal S
    Dig Dis Sci; 2008 Sep; 53(9):2521-3. PubMed ID: 18259864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indices of granulocyte activity in ulcerative colitis and Crohn's disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Dan Med Bull; 1977 Apr; 24(2):72-6. PubMed ID: 852316
    [No Abstract]   [Full Text] [Related]  

  • 4. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C; Descos L; André F; Vignal J; Druguet M
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract]   [Full Text] [Related]  

  • 5. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential analysis of Crohn's disease and ulcerative colitis by mass spectrometry.
    Freiwald A; Mao L; Kodelja V; Kliem M; Schuldt D; Schreiber S; Franke A; Sauer S
    Inflamm Bowel Dis; 2011 Apr; 17(4):1051-2. PubMed ID: 20645316
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum lysozyme in inflammatory bowel disease.
    Nugent FW; Mallari R; George H; Ridley N
    Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D; Pawlica D; Ciećko-Michalska I; Solnica B; Mach T
    Przegl Lek; 2010; 67(2):114-8. PubMed ID: 20557011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte chemotaxis in ulcerative colitis.
    Belsheim J; Gnarpe H; Swahn A
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):75-9. PubMed ID: 6711311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and humoral indices of disease activity in inflammatory bowel disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Digestion; 1978; 17(5):387-95. PubMed ID: 680416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-derived microparticles in Crohn's disease.
    Chamouard P; Desprez D; Hugel B; Kunzelmann C; Gidon-Jeangirard C; Lessard M; Baumann R; Freyssinet JM; Grunebaum L
    Dig Dis Sci; 2005 Mar; 50(3):574-80. PubMed ID: 15810645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers to differentiate between ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Meuwissen SG; von Blomberg BM; van de Merwe JP; Devillé WL; Fonk JC; Peña AS
    J Clin Pathol; 1995 Apr; 48(4):346-50. PubMed ID: 7615855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
    Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
    Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Marginal area between ulcerative colitis and Crohn's disease].
    Mussche M; Elewaut A; Barbier F
    Tijdschr Gastroenterol; 1971; 14(4):258-71. PubMed ID: 5160650
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
    Macfarlane PI; Miller V; Wells F; Richards B
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.